文献速递胸部肿瘤

肺癌家族史亲属中的低剂量计算机断层扫描筛查

Low-Dose Computed Tomography Screening in Relatives With a Family History of Lung Cancer.
PubMed 文献 · J Thorac Oncol · 2023-07-05

多中心前瞻性研究纳入1102名有肺癌家族史的无症状一级或二级亲属,每年进行最多三轮低剂量计算机断层扫描筛查,总体肺癌检出率为4.5%(50/1102),家族中多例肺癌者检出率高于单例家族,从不吸烟者及较年轻者检出率较高,母亲或母系亲属肺癌史增加肺癌风险,作者认为需随机对照试验确认死亡率获益。

要点

  • 有肺癌家族史的无症状亲属中低剂量计算机断层扫描筛查总体肺癌检出率为4.5%(50/1102)。
  • 家族中多例肺癌者检出率为9.4%(19/202),单例家族为3.7%(21/569)。
  • 母亲或母系亲属肺癌史与肺癌风险升高相关,改良率比分别为4.46和5.41。

核心结论

  • 肺癌家族史是肺癌的危险因素,且在家族中多例肺癌、从不吸烟者、较年轻成人及有母亲或母系亲属肺癌史者中风险增加。
  • 作者认为需随机对照试验确认低剂量计算机断层扫描筛查在该人群中的死亡率获益。

研究设计与样本

  • 多中心前瞻性研究,2007年至2011年纳入1102名有肺癌家族史的无症状一级或二级亲属,每年进行最多三轮低剂量计算机断层扫描筛查,末次随访日期为2021年5月5日。
  • 纳入人群中805名来自单例家族、297名来自多例家族,女性占54.2%,从不吸烟者占70.0%。

主要发现

  • 总体肺癌检出率为4.5%(50/1102)。
  • 多例家族中从不吸烟者检出率为9.4%(19/202),吸烟者为4.4%(4/91);单例家族中从不吸烟者检出率为3.7%(21/569),吸烟者为2.7%(6/223)。
  • 检出病例中68.0%为I期、22.0%为IV期。
  • 初始筛查后3年内诊断的肺癌趋于更年轻、检出率更高且为I期;此后更多为III-IV期,且66.7%(16/24)在初始计算机断层扫描中为阴性或半阳性结节。
  • 6年内,仅母亲肺癌史(改良率比=4.46,95%置信区间:2.32-8.56)或母系亲属肺癌史(改良率比=5.41,95%置信区间:2.84-10.30)增加肺癌风险。

局限性

  • 作者认为需随机对照试验确认低剂量计算机断层扫描筛查在有肺癌家族史人群中的死亡率获益。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: The role of a family history of lung cancer (LCFH) in screening using low-dose computed tomography (LDCT) has not been prospectively investigated with long-term follow-up. METHODS: A multicenter prospective study with up to three rounds of annual LDCT screening was conducted to determine the detection rate of lung cancer (LC) in asymptomatic first- or second-degree relatives of LCFH. RESULTS: From 2007 to 2011, there were 1102 participants enrolled, including 805 and 297 from simplex and multiplex families (MFs), respectively (54.2% women and 70.0% never-smokers). The last follow-up date was May 5, 2021. The overall LC detection rate was 4.5% (50 of 1102). The detection rate in MF was 9.4% (19 of 202) and 4.4% (4 of 91) in never-smokers and in those who smoked, respectively. The corresponding rates for simplex families were 3.7% (21 of 569) and 2.7% (6 of 223), respectively. Of these, 68.0% and 22.0% of cases with stage I and IV diseases, respectively. LC diagnoses within a 3-year interval from the initial screening tend to be younger, have a higher detection rate, and have stage I disease; thereafter, more stage III-IV disease and 66.7% (16 of 24) with negative or semipositive nodules in initial computed tomography scans. Within the 6-year interval, only maternal (modified rate ratio = 4.46, 95% confidence interval: 2.32-8.56) or maternal relative history of LC (modified rate ratio = 5.41, 95% confidence interval: 2.84-10.30) increased the risk of LC. CONCLUSIONS: LCFH is a risk factor for LC and is increased with MF history, among never-smokers, younger adults, and those with maternal relatives with LC. Randomized controlled trials are needed to confirm the mortality benefit of LDCT screening in those with LCFH.

来源:J Thorac Oncol,查看原文。版权归原作者所有。

引用

  1. Wang CL, Hsu KH, Chang YH, et al. Low-Dose Computed Tomography Screening in Relatives With a Family History of Lung Cancer. J Thorac Oncol. 2023. PMID: 37414358. doi:10.1016/j.jtho.2023.06.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。